Cart
sales@molnova.com
PST-1
CAS No. 1801769-39-0
PST-1( —— )
Catalog No. M12744 CAS No. 1801769-39-0
PST-1 is a photoswitchable inhibitor of microtubule with EC50 of 0.5 uM under 390 nm irradiation in the MDA-MB-231 human breast cancer cell lines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePST-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPST-1 is a photoswitchable inhibitor of microtubule with EC50 of 0.5 uM under 390 nm irradiation in the MDA-MB-231 human breast cancer cell lines.
-
DescriptionPST-1 is a photoswitchable inhibitor of microtubule with EC50 of 0.5 uM under 390 nm irradiation in the MDA-MB-231 human breast cancer cell lines; 100-fold more cytotoxic than in the dark.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMicrotubule/Tubulin
-
RecptorMicrotubule/Tubulin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1801769-39-0
-
Formula Weight318.329
-
Molecular FormulaC16H18N2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(Z)-2-methoxy-5-((3,4,5-trimethoxyphenyl)diazenyl)phenol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Borowiak M, et al. Cell. 2015 Jul 16;162(2):403-11.
molnova catalog
related products
-
Sodium?Dichloroaceta...
Dichloroacetate ion inhibits pyruvate dehydrogenase kinase, resulting in the inhibition of glycolysis and a decrease in lactate production.
-
MAP4343
Map4343 is a 3-methyl ether derivative of pregnenolone. Map4343 binds to microtubule associated protein 2 (MAP2) in vitro and stimulates tubulin polymerization, resulting in enhanced neurite extension and protection of neurons from neurotoxic agents.
-
PST-1P
PST-1P is a photoswitchable inhibitor of microtubule with EC50 of 0.7 uM under 390 nm irradiation in the MDA-MB-231 human breast cancer cell lines.
